Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL‐3), IL‐6, granulocyte‐macrophage colony stimulating factor (GM‐CSF) and stem cell factor (SCF) in serum‐supplemented and serum‐free medium

Publisher Website
Google Scholar
Abstract
We evaluated the growth of cord blood myeloid progenitors or colony forming units granulocyte‐macrophage (CFU‐GM) and their response to various recombinant growth factors or colony stimulating factors (CSFs): interleukin 3 (IL‐3), IL‐6, granulocyte‐macrophage CSF (GM‐CSF) and stem cell factor (SCF). Using classical stimulant (human placenta conditioned medium or HPCM), we observed a significantly higher day‐14/day‐7 CFU‐GM ratio in CB than in bone marrow (BM). The association of IL‐3, IL‐6, GM‐CSF and SCF induced significantly more CB day‐14 CFU‐GM than HPCM. This effect is significantly greater in CB than in bone marrow. Since fetal calf serum (FCS) is known to contain inhibitors, we have compared the ability of CSFs to induce CFU‐GM formation in FCS‐supplemented and FCS‐free culture. In CB, using HPCM, we obtained significantly more CFU‐GM in FCS‐free medium than in FCS‐supplemented medium. This difference was corrected by the addition of anti‐transforming growth factor‐β (TGF‐β) neutralizing antibody. However, with the association of the four CSFs, no significant difference between FCS and FCS‐free culture was observed. In conclusion: a) day‐14/day‐7 CFU‐GM ratio was higher in CB than in BM indicating that CB CFU‐GM are more primitive than BM CFU‐GM; b) FCS can be successfully replaced by serum‐free medium; c) FCS contains inhibitors of day‐14 CFU‐GM and among them TGF‐β; and d) the association IL‐3, SCF, GM‐CSF and IL‐6 seems able to totally overcome the inhibitory effect of FCS.